Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes

PURPOSE: Doxorubicin causes cardiac injury and cardiomyopathy in children with acute lymphoblastic leukemia (ALL). Measuring biomarkers during therapy might help individualize treatment by immediately identifying cardiac injury and cardiomyopathy. PATIENTS AND METHODS: Children with high-risk ALL we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lipshultz, Steven E., Miller, Tracie L., Scully, Rebecca E., Lipsitz, Stuart R., Rifai, Nader, Silverman, Lewis B., Colan, Steven D., Neuberg, Donna S., Dahlberg, Suzanne E., Henkel, Jacqueline M., Asselin, Barbara L., Athale, Uma H., Clavell, Luis A., Laverdière, Caroline, Michon, Bruno, Schorin, Marshall A., Sallan, Stephen E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341148/
https://ncbi.nlm.nih.gov/pubmed/22370326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.3404
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados